Treatment of experimental autoimmune myasthenia gravis in rabbits with leupeptin, a protease inhibitor
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 82 (1-3) , 133-143
- https://doi.org/10.1016/0022-510x(87)90013-x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Myasthenia gravis and myasthenic syndromesAnnals of Neurology, 1984
- Myasthenia gravis: immunobiology of a receptor disorderTrends in Neurosciences, 1983
- Complement (C3)‐Receptor‐Mediated Phagocytosis of Agarose Beads by Mouse MacrophagesScandinavian Journal of Immunology, 1983
- Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties.The Journal of cell biology, 1983
- Experimental myasthenia: Lack of correlation between the autoantibody titer and the reduction of acetylcholine‐controlled ionic channels measured at functioning endplatesMuscle & Nerve, 1983
- Leupeptin inhibits the C3/5 convertase CVFBb of the complement systemBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- The Biology of Myasthenia GravisAnnual Review of Neuroscience, 1981
- Mechanisms of acetylcholine receptor loss in myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- Affinity labeling of one of two α-neurotoxin binding sites in acetylcholine receptor from Torpedo californicaBiochemistry, 1978
- Therapeutic Trials in Muscular DystrophyArchives of Neurology, 1977